Currently, there are a few or none marketed gabapentin veterinary products, leading to treatment with compounded dosage forms or off-label use of human-marketed products.

With the said approaches, there are significant risks of preparation errors, rendering these practices suboptimal. A new manufacturing technique to accurately and rapidly prepare veterinary dosage forms close to the point-of-care is needed.
The method was successfully applied to determine the drug content in the prepared semi-solid extrusion 3D-printed dosage forms. This study proved that pet-friendly tailored gabapentin dosage forms could easily be manufactured by semi-solid extrusion 3D printing and UV–Vis spectrophotometrically analyzed with the ascorbic acid derivatization method.
www.brinter.cm

 

Meet Our Sponsors

Latest Sponsor News

Articles Most Read

Latest News

Statistics

Articles View Hits
1625679

Who's Online

We have 44 guests and no members online